Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Gibberellin insensitive dwarf 1 (GID1) receptor is a nuclear and cytosolic protein that serves as the primary sensor for gibberellins (GAs), a class of tetracyclic diterpene hormones essential for plant growth and development. GID1 belongs to the alpha/beta-hydrolase superfamily, but it has evolved to function as a ligand-dependent chaperone rather than an enzyme, lacking the essential catalytic residues. When a bioactive gibberellin binds within its deep hydrophobic pocket, the N-terminal extension of GID1 undergoes a conformational change that enables it to interact with the GRAS domain of DELLA proteins, which are master repressors of GA-responsive growth. This interaction facilitates the recruitment of an E3 ubiquitin ligase complex (SCF-SLY1 in Arabidopsis or SCF-GID2 in rice), leading to the polyubiquitination and subsequent 26S proteasomal degradation of the DELLA proteins. The removal of DELLA proteins relieves the repression of GA-responsive genes, thereby promoting processes such as seed germination, stem elongation, and floral transition. While GID1 is not a therapeutic target for human clinical diseases, it is a critical target in agricultural biotechnology for the development of high-yield, semi-dwarf crop varieties and is increasingly employed in synthetic biology as a tool for chemically induced dimerization (CID) systems.
Gibberellin-dependent recruitment of DELLA repressors to the SCF-SLY1/GID2 E3 ubiquitin ligase complex for proteasomal degradation.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gibberellin insensitive dwarf 1 receptor (GID1).